Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BLLN

Billiontoone Inc

May 29 • 04:00PM ET

98.99

+1.19 1.22 %

Healthcare • Diagnostics & Research • USA • Mid • NASD

Peers: NTRA RDNT A MTD WAT BRKR DHR TMO BIO VEEV

| Held by: VTI VB VBR VXF LFSC SMLF SCHA TMSL ONEQ GNOM

Scroll to Statements

Index	-	P/E	213.94	EPS (ttm)	0.46	Insider Own	64.05%	Shs Outstand	41.43M	Perf Week	14.90%
Market Cap	4.55B	Forward P/E	84.20	EPS next Y	1.18	Insider Trans	0.00%	Shs Float	16.54M	Perf Month	34.30%
Enterprise Value	4.16B	PEG	0.60	EPS next Q	0.18	Inst Own	17.45%	Short Float	8.86%	Perf Quarter	29.69%
Income	23.65M	P/S	12.84	EPS this Y	544.90%	Inst Trans	5.55%	Short Ratio	2.89	Perf Half Y	-23.80%
Sales	354.54M	P/B	9.00	EPS next Y	30.22%	ROA	0.36%	Short Interest	1.47M	Perf YTD	20.96%
Book/sh	11.00	P/C	8.47	EPS next 5Y	141.18%	ROE	0.52%	52W High	138.70 -28.63%	Perf Year	-
Cash/sh	11.68	P/FCF	-	EPS past 3/5Y	- -	ROIC	3.67%	52W Low	61.96 59.76%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	88.85	Sales past 3/5Y	106.24% -	Gross Margin	70.40%	Volatility	8.45% 9.97%	Perf 5Y	-
Dividend TTM	-	EV/Sales	11.73	EPS Y/Y TTM	168.38%	Oper. Margin	10.20%	ATR (14)	7.68	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.58	Sales Y/Y TTM	98.49%	Profit Margin	6.67%	RSI (14)	61.75	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	10.92	EPS Q/Q	479.93%	SMA20	12.86%	Beta	-	Target Price	117.71
Payout	0.00%	Debt/Eq	0.29	Sales Q/Q	83.82%	SMA50	19.05%	Rel Volume	0.80	Prev Close	97.80
Employees	713	LT Debt/Eq	0.27	Earnings	May 06 AMC	SMA200	12.37%	Avg Volume	506.89K	Price	98.99
IPO	Nov 06, 2025	Option/Short	Yes / Yes	EPS/Sales Surpr.	982.80% 11.59%	Trades		Volume	405,885	Change	1.22%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-06-26	Initiated	Guggenheim	Buy	$120
Dec-01-25	Initiated	William Blair	Outperform
Dec-01-25	Initiated	Wells Fargo	Equal Weight	$110
Dec-01-25	Initiated	Stifel	Buy	$145
Dec-01-25	Initiated	Piper Sandler	Overweight	$150
Dec-01-25	Initiated	JP Morgan	Overweight	$150
Dec-01-25	Initiated	Jefferies	Hold	$117
Dec-01-25	Initiated	BTIG Research	Buy	$160

May-27-26 04:05PM	BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference (GlobeNewswire) +7.74% +7.45%
May-07-26 08:30AM	BillionToOne, Inc. Q1 2026 Earnings Call Summary (Moby) +14.13%
May-06-26 05:03PM	BillionToOne: Q1 Earnings Snapshot (Associated Press)
04:05PM	BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance (GlobeNewswire)
May-01-26 07:00PM	BillionToOne Launches Unity Confirm: A category-defining test that bridges the gap between screening and invasive diagnostics (PR Newswire) -6.93%
08:05AM	Loading…
Apr-15-26 08:05AM	BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026 (GlobeNewswire)
Apr-02-26 09:00AM	BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology (PR Newswire)
Mar-06-26 07:03AM	What Makes BillionToOne (BLLN) an Attractive Bet? (Insider Monkey)
Mar-05-26 12:01AM	BillionToOne Inc (BLLN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com) -10.71%
Mar-04-26 07:00PM	Billiontoone Q4 Earnings Call Highlights (MarketBeat)
06:00PM	BillionToOne (BLLN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
04:38PM	BillionToOne: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance (GlobeNewswire)
Feb-27-26 03:40AM	BillionToOne (BLLN) Launches Two New Add-ons for Northstar Select (Insider Monkey) +6.89%
Feb-17-26 08:05AM	BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 (GlobeNewswire) +5.16%
09:00AM	Loading…
Feb-10-26 09:00AM	BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select (PR Newswire)
Feb-09-26 12:29PM	BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care (PR Newswire)
Jan-23-26 10:23AM	Class of 2025 IPOs: 3 Stocks With Bullish Charts (Barrons.com)
Jan-15-26 08:58AM	BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare (PR Newswire)
Jan-13-26 09:43AM	What's Going On With BillionToOne Shares Tuesday? (Benzinga)
04:24AM	BillionToOne Showcases Single-Molecule NGS at JPMorgan, Lifts 202526 Revenue Outlook (MarketBeat)
Jan-12-26 08:05AM	BillionToOne Provides Guidance for 2026 (GlobeNewswire) +15.37%
Jan-06-26 09:00AM	BillionToOne Announces Selection of Northstar Select as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East (PR Newswire)
Jan-01-26 12:13AM	2 New IPO Stocks Enter the Fray; J.P. Morgan Says Buy (TipRanks)
Dec-23-25 08:05AM	BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -9.57%
Dec-09-25 04:07PM	BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair (PR Newswire) -5.32%
04:05PM	BillionToOne Reports Third Quarter 2025 Results (GlobeNewswire)
07:10AM	Medline seeks $5.37bn in largest healthcare IPO of 2025 (Medical Device Network)
Dec-03-25 04:00PM	AppLovin Stock Rides Swarm Of Setups Beyond Just Mining, Medical Names (Investor's Business Daily) -10.58%
Dec-02-25 08:05AM	BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 (GlobeNewswire)
12:16PM	Loading…
Dec-01-25 12:16PM	BillionToOne wins bullish backing, but Jefferies and Wells Fargo urge caution (Investing.com) -13.17%
09:46AM	Carvana initiated, Zscaler downgraded: Wall Street's top analyst calls (The Fly)
Nov-26-25 12:59PM	IPO Stock Taps Massive Medicare Market, Soars Into Buy Range (Investor's Business Daily)
Nov-25-25 05:00PM	IPO Stock Taps Massive Medicare Market, Soars Into Buy Range (Investor's Business Daily) +8.32%
Nov-18-25 12:34AM	Jim Cramer Says BillionToOne Has a "Fantastic Story" Within the Diagnostics Space (Insider Monkey) +6.41%
Nov-07-25 04:05PM	BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) -8.18%
Nov-06-25 05:02PM	Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering (PR Newswire)
03:39PM	What Shutdown? The IPO Window Is Still Open for Some Companies (Barrons.com)
Nov-05-25 09:53PM	BillionToOne Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)

BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. BillionToOne was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.

Co-FounderDr. Oguzhan Atay Ph.D.

Co-FounderDr. David Tsao Ph.D.

Chief Administrative OfficerMr. John D. Lister J.D.

M.B.A.Mr. Ross Taylor Jr.

VP of Business Operations & Chief of StaffMs. Jean Hayden

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BLLN

Billiontoone Inc

Upgrade your Finviz experience